|
Delayed
Nasdaq Stockholm
02:13:35 01/09/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 19.74 SEK | -1.30% |
|
+3.89% | -12.65% |
| 28/08 | Synact Pharma to present new preclinical data for resomelagon at WCI | FW |
| 20/08 | SynAct Pharma AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -1.30% | +3.89% | +8.11% | +30.73% | -12.65% | +8.22% | -83.16% | -80.72% | +220.98% | 12Cr | |
| -1.52% | -7.23% | +0.69% | +4.68% | +7.63% | +57.90% | +108.72% | +347.84% | +1,387.76% | 1,03100Cr | |
| -0.82% | -2.63% | +3.71% | +17.98% | +28.46% | +50.05% | +64.43% | +53.56% | +122.77% | 64TCr | |
| +0.37% | -3.06% | +2.18% | +17.78% | +12.22% | +21.87% | +74.48% | +112.30% | +300.03% | 45TCr | |
| -2.08% | -6.91% | -2.49% | +8.63% | +5.06% | +32.51% | +32.46% | -6.24% | +43.79% | 35TCr | |
| +4.01% | +1.26% | +1.39% | +12.70% | +17.12% | +26.41% | +43.72% | +51.39% | +65.84% | 29TCr | |
| -1.46% | -2.58% | -6.60% | -12.18% | -14.45% | -0.44% | +10.65% | +38.57% | +140.33% | 25TCr | |
| -0.59% | -3.15% | +11.61% | +30.61% | +31.34% | +49.83% | +67.70% | +90.61% | +152.78% | 23TCr | |
| +0.03% | -2.26% | -4.57% | +2.67% | -10.07% | -19.88% | -54.08% | -6.80% | +87.08% | 20TCr | |
| +0.45% | -0.27% | +12.39% | +11.62% | +19.23% | +29.84% | +91.34% | +101.07% | +86.71% | 18TCr | |
| +1.79% | +1.75% | +13.79% | +8.71% | +14.30% | +14.94% | -19.56% | -38.22% | -18.22% | 16TCr | |
| +0.52% | -0.56% | +14.13% | +24.21% | +20.11% | +35.79% | +56.32% | +171.87% | +476.15% | 14TCr | |
| +0.35% | -0.70% | +2.30% | +16.84% | +23.86% | +41.61% | +8.37% | -0.07% | +16.41% | 14TCr | |
| +0.12% | -2.31% | +3.25% | +3.72% | -7.01% | -9.17% | -22.00% | -12.72% | +12.51% | 11TCr | |
| -0.46% | -2.43% | -4.50% | +0.11% | +1.10% | +27.43% | +32.81% | +0.93% | -9.97% | 10TCr | |
| +0.30% | -0.76% | +0.03% | -9.53% | -15.88% | +6.35% | +55.58% | +60.96% | +541.05% | 7.12TCr | |
| +1.39% | +0.83% | +6.02% | +19.75% | +20.89% | +30.79% | +29.66% | +58.87% | +28.18% | 5.76TCr | |
| -0.89% | +0.25% | +1.14% | +38.34% | +31.32% | +74.44% | -3.84% | +3.09% | -49.36% | 5.6TCr | |
| -2.64% | -3.50% | -15.70% | -8.21% | -22.66% | -30.44% | +9.30% | +1.03% | +187.21% | 4.51TCr | |
| +0.26% | -0.38% | +1.40% | +12.73% | -1.71% | +2.13% | +14.23% | - | - | 4.4TCr | |
| Average | -0.19% | -1.31% | +2.41% | +11.59% | +7.41% | +22.51% | +25.86% | +49.86% | +199.58% | 22.74TCr | |
| Weighted average by Cap. | -0.41% | -3.27% | +2.23% | +10.56% | +11.42% | +33.75% | +54.62% | +117.34% | +420.75% |
- Stock Market
- Stocks
- SYNACT Stock
- Sector SynAct Pharma AB
Select your edition
All financial news and data tailored to specific country editions
